NDC 73377-094-01 - Losartan Potassium
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 73377-094
- Requested NDC
- 73377-094-01
- Package NDCs from labels
- 73377-094-01, 73377-094-02, 73377-094-03, 73377-094-04, 73377-094-05, 73377-094-06, 73377-094-07
- Manufacturer
- AX Pharmaceutical Corp
- Effective date
- 2026-05-19
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Losartan Potassium - AX Pharmaceutical Corp | AX Pharmaceutical Corp | 2026-05-19 | BULK INGREDIENT - ANIMAL DRUG |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 73377-094-01 | Losartan Potassium | 100 g in 1 JAR | POWDER | 100 | 7 | |
| 73377-094-02 | Losartan Potassium | 25 g in 1 JAR | POWDER | 25 | 7 | |
| 73377-094-03 | Losartan Potassium | 1000 g in 1 JAR | POWDER | 1000 | 7 | |
| 73377-094-04 | Losartan Potassium | 97 g in 1 JAR | POWDER | 97 | 7 | |
| 73377-094-05 | Losartan Potassium | 80 g in 1 JAR | POWDER | 80 | 7 | |
| 73377-094-06 | Losartan Potassium | 500 g in 1 JAR | POWDER | 500 | 7 | |
| 73377-094-07 | Losartan Potassium | 1500 g in 1 JAR | POWDER | 1500 | 7 |
DailyMed Dashboard NDC Coverage#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Losartan potassium | LOSARTAN POTASSIUM | REMEDYREPACK INC. | a397502e-abe7-49cf-97c7-d53a616947eb | 2026-09-03 | Boxed warning, Warnings, Adverse reactions | 3ST302B24A |
| Losartan Potassium | LOSARTAN POTASSIUM | Cardinal Health 107, LLC | 021cd76a-b093-4704-8410-5e7d01e20a54 | 2026-08-27 | Boxed warning, Warnings, Adverse reactions | 3ST302B24A |
| Losartan Potassium | LOSARTAN POTASSIUM | REMEDYREPACK INC. | e136356b-e4d2-4e00-a409-35825c5637c9 | 2026-08-11 | Boxed warning, Warnings, Adverse reactions | 3ST302B24A |
| Losartan Potassium and Hydrochlorothiazide | LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE | REMEDYREPACK INC. | fd07d24c-6db1-4f6b-b226-68abba3a3321 | 2026-08-07 | Boxed warning, Warnings, Adverse reactions | 3ST302B24A |
| Losartan Potassium and Hydrochlorothiazide | LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE | REMEDYREPACK INC. | 446e6998-01f6-4de0-be57-7fecf5448e95 | 2026-08-07 | Boxed warning, Warnings, Adverse reactions | 3ST302B24A |
| Losartan Potassium | LOSARTAN POTASSIUM | Redpharm Drug | 5833c02c-9957-a069-e063-6294a90ad3e4 | 2026-08-04 | Boxed warning, Warnings, Adverse reactions | 3ST302B24A |
| Losartan Potassium and Hydrochlorothiazide | LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE | REMEDYREPACK INC. | 9f9cd7a7-be95-4ea8-8247-eb7ecbd36936 | 2026-07-28 | Boxed warning, Warnings, Adverse reactions | 3ST302B24A |
| Losartan Potassium | LOSARTAN POTASSIUM | Major Pharmaceuticals | c15387df-87a4-4784-acb5-7dd550498f8f | 2026-07-27 | Boxed warning, Warnings, Adverse reactions | 3ST302B24A |
| Losartan Potassium | LOSARTAN POTASSIUM | REMEDYREPACK INC. | df4f55f0-fb11-4f6f-a7ed-127b50f955fc | 2026-07-22 | Boxed warning, Warnings, Adverse reactions | 3ST302B24A |
| Losartan Potassium | LOSARTAN POTASSIUM | Zydus Pharmaceuticals USA Inc. | 3233c707-70b6-4c29-8210-913eeb2a38ed | 2026-07-20 | Boxed warning, Warnings, Adverse reactions | 3ST302B24A |
| Losartan Potassium | LOSARTAN POTASSIUM | REMEDYREPACK INC. | f7cf8a7d-90f1-46a3-abff-1eb316aa7d72 | 2026-07-17 | Boxed warning, Warnings, Adverse reactions | 3ST302B24A |
| Losartan Potassium and Hydrochlorothiazide | LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE | Lupin Pharmaceuticals, Inc. | ee1eaaf6-050b-48af-942b-5e3451edc164 | 2026-07-16 | Boxed warning, Warnings, Adverse reactions | 3ST302B24A |
| Losartan Potassium | LOSARTAN | Preferred Pharmaceuticals Inc. | 9501dfaa-c8cf-46d6-8bec-936c4fd8fe03 | 2026-07-16 | Boxed warning, Warnings, Adverse reactions | 3ST302B24A |
| Losartan Potassium | LOSARTAN POTASSIUM | REMEDYREPACK INC. | 6f39f7f9-edac-45ca-9ee2-c2ecad0915ab | 2026-07-10 | Boxed warning, Warnings, Adverse reactions | 3ST302B24A |
| Losartan Potassium | LOSARTAN POTASSIUM | PD-Rx Pharmaceuticals, Inc. | 1843ee4b-1afc-4992-993a-4b0e03e785fc | 2026-07-07 | Boxed warning, Warnings, Adverse reactions | 3ST302B24A |
| Losartan Potassium | LOSARTAN POTASSIUM | PD-Rx Pharmaceuticals, Inc. | 9b3ddaa2-a835-736a-e053-2995a90aff08 | 2026-07-07 | Boxed warning, Warnings, Adverse reactions | 3ST302B24A |
| Losartan Potassium | LOSARTAN POTASSIUM | REMEDYREPACK INC. | 25c93638-7016-47d2-a57c-e4a5245ca41b | 2026-06-30 | Boxed warning, Warnings, Adverse reactions | 3ST302B24A |
| Losartan Potassium | LOSARTAN POTASSIUM | Unit Dose Solutions, Inc. | 5529733c-1e3b-e590-e063-6294a90a765c | 2026-06-26 | Boxed warning, Warnings, Adverse reactions | 3ST302B24A |
| Losartan Potassium | LOSARTAN POTASSIUM | Unit Dose Solutions, Inc. | 552a2f78-6318-310f-e063-6394a90abb15 | 2026-06-26 | Boxed warning, Warnings, Adverse reactions | 3ST302B24A |
| Losartan Potassium | LOSARTAN POTASSIUM | REMEDYREPACK INC. | 41069514-0491-41fe-b7fe-a52d42d33848 | 2026-06-24 | Boxed warning, Warnings, Adverse reactions | 3ST302B24A |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.